ET-356

N/A

Report date: 2025/01/26 17:00:45

Base Information

Drug NameET-356

Drug Alias NameCAR Gamma Delta T-cell Therapy (Expression Therapeutics)CAR T-cell Therapy (Expression Therapeutics)ET-356

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Gamma delta T-cell therapy

Mechanisms of ActionT lymphocytes stimulantsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsLymphomaLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesExpression Therapeutics Llc

China Registration ClassN/A

Develop Information

Active CompaniesExpression Therapeutics Llc

Inactive CompaniesN/A

Active IndicationsLymphomaLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A